Figure 2From: A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan Flow chart summarizing the enrolment, randomization, and follow-up of study patients. Back to article page